1 Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
2 Department of Otolaryngology-Head and Neck Surgery, Wake Forest University, Winston-Salem, North Carolina, USA.
Otolaryngol Head Neck Surg. 2019 Apr;160(4):712-719. doi: 10.1177/0194599818815109. Epub 2018 Nov 27.
The microbiology of pediatric complicated acute rhinosinusitis (ARS) has evolved, and our current understanding of pathogenic organisms is limited. The objectives of this study are to describe the incidence of pathogens causing complicated ARS requiring surgical intervention at our institution over a 10-year period as well as their associated treatment outcomes.
Retrospective cohort study.
A single tertiary care children's hospital.
Data were reviewed from all patients who underwent surgery for complicated ARS and had positive culture data from 2006 to 2016. Associations among pathogens, complications, and outcomes were analyzed with Pearson χ and Wilcoxon rank-sum tests.
Eighty-nine patients met criteria. Complications included orbital infections (78%), intracranial infections (48%), Pott's puffy tumor (13%), and cavernous sinus thrombosis (9.0%). Bacterial isolates were majority polymicrobial (55%) and included Streptococcus species (58%), Staphylococcus species (49%; including methicillin-resistant S aureus [MRSA], 11%), and anaerobic bacteria (35%). S pneumoniae (9.0%), Haemophilus species (4.5%), and Moraxella catarrhalis (1.1%) were relatively uncommon. Bacterial isolates were similar among patients with all types of complications.
Among a large cohort of pediatric patients with complicated ARS, most bacterial isolates were polymicrobial, with Streptococcus and Staphylococcus species contributing to the majority of cases. S aureus species, including MRSA and anaerobic pathogens, were common. The pattern of bacterial isolates was similar among patients with all types of complications of ARS. We suggest treatment for complicated ARS with broad-spectrum antibiotics with coverage for Streptococcus species, Staphylococcus species including MRSA, and anaerobic bacteria.
儿科复杂性急性鼻-鼻窦炎(ARS)的微生物学已经发生了变化,我们目前对病原体的认识有限。本研究的目的是描述在我们的机构中,10 年来需要手术干预的复杂性 ARS 致病病原体的发生率,以及它们相关的治疗结果。
回顾性队列研究。
一家单中心三级儿童医院。
对 2006 年至 2016 年间所有因复杂性 ARS 而行手术且培养阳性的患者数据进行了回顾性分析。采用 Pearson χ 和 Wilcoxon 秩和检验分析病原体、并发症和结果之间的关系。
89 例患者符合标准。并发症包括眼眶感染(78%)、颅内感染(48%)、波特氏肿(13%)和海绵窦血栓形成(9.0%)。细菌分离株主要为混合感染(55%),包括链球菌属(58%)、葡萄球菌属(49%,包括耐甲氧西林金黄色葡萄球菌[MRSA],11%)和厌氧菌(35%)。肺炎链球菌(9.0%)、流感嗜血杆菌(4.5%)和卡他莫拉菌(1.1%)相对少见。所有类型并发症患者的细菌分离株相似。
在一组较大的儿科复杂性 ARS 患者中,大多数细菌分离株为混合感染,链球菌属和葡萄球菌属占大多数。金黄色葡萄球菌属,包括 MRSA 和厌氧病原体,很常见。ARS 所有类型并发症患者的细菌分离株模式相似。我们建议对复杂性 ARS 采用广谱抗生素治疗,覆盖链球菌属、包括 MRSA 的葡萄球菌属和厌氧菌。